Curiteva marked the first cases using its Inspire Standalone ALIF System. This completes the company’s anterior launch strategy and establishes the Inspire portfolio as a comprehensive, 360-degree solution for surgeons addressing spinal pathologies.
Alpha launch is underway, with a ramp-up slated for 1Q26. A full commercial release is planned for later in the year.
Inspire Standalone ALIF serves as the flagship of Curiteva’s anterior portfolio, which includes the monolithic Inspire A and Acumen Anterior Plate. With this addition, the company now offers fully integrated solutions of the Inspire Technology across cervical, posterior lumbar, and anterior lumbar approaches.
Dr. Randy Dryer, Curiteva’s CMO, was the first to implant the device. “Bringing the Inspire Standalone ALIF across the finish line and into the operating room is a significant accomplishment,” states Dr. Dryer following the procedure. “As we have seen with this technology, the visual verification of bone growth through the implant, paired with outstanding clinical results, aligns perfectly with what surgeons are seeking. I’m confident this implant will define a new standard for standalone ALIF procedures, delivering a best-in-class solution designed to enhance patient outcomes. I’m excited to incorporate this approach to my Inspire armamentarium.”
Curiteva marked the first cases using its Inspire Standalone ALIF System. This completes the company's anterior launch strategy and establishes the Inspire portfolio as a comprehensive, 360-degree solution for surgeons addressing spinal pathologies.
Alpha launch is underway, with a ramp-up slated for 1Q26. A full commercial release is planned...
Curiteva marked the first cases using its Inspire Standalone ALIF System. This completes the company’s anterior launch strategy and establishes the Inspire portfolio as a comprehensive, 360-degree solution for surgeons addressing spinal pathologies.
Alpha launch is underway, with a ramp-up slated for 1Q26. A full commercial release is planned for later in the year.
Inspire Standalone ALIF serves as the flagship of Curiteva’s anterior portfolio, which includes the monolithic Inspire A and Acumen Anterior Plate. With this addition, the company now offers fully integrated solutions of the Inspire Technology across cervical, posterior lumbar, and anterior lumbar approaches.
Dr. Randy Dryer, Curiteva’s CMO, was the first to implant the device. “Bringing the Inspire Standalone ALIF across the finish line and into the operating room is a significant accomplishment,” states Dr. Dryer following the procedure. “As we have seen with this technology, the visual verification of bone growth through the implant, paired with outstanding clinical results, aligns perfectly with what surgeons are seeking. I’m confident this implant will define a new standard for standalone ALIF procedures, delivering a best-in-class solution designed to enhance patient outcomes. I’m excited to incorporate this approach to my Inspire armamentarium.”
Copy to clipboard 
